Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Sleep Wake Disorders 1Sezary Syndrome 1Prostatic Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Hematologic Neoplasms 1

Interventions

fludarabine phosphate 17Mycophenolic Acid 17Tacrolimus 15Peripheral Blood Stem Cell Transplantation 14Whole-Body Irradiation 13Cyclophosphamide 12Cyclosporine 11Methotrexate 10Antilymphocyte Serum 10Busulfan 9Radiotherapy 6pembrolizumab 5Methylprednisolone 5Alemtuzumab 5merphos 4Transplantation 4Rituximab 4Melphalan 4Flow Cytometry 4Cord Blood Stem Cell Transplantation 4Bexarotene 4sargramostim 3Therapeutics 3Sirolimus 3Panobinostat 3Lenalidomide 3Gemcitabine 3Dexamethasone 3Cyclosporins 3zanolimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Sezary Syndrome × Ultraviolet Therapy × Clear all
NCT00030589 2013-12-18

Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma

National Cancer Institute (NCI)

Phase 2 Unknown
DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡